(HealthDay News) -- Here are the latest clinical trials,
This study will evaluate an investigational drug for relapsing
remitting multiple sclerosis. You may qualify if you are 18 to 55
and have had a relapse within the last year.
The research site is in Sarasota, Fla.
This study, for people 18 or older, will evaluate the safety and
effectiveness of two FDA approved medications to treat
The research site is in Raleigh, N.C.
Diabetic Peripheral Neuropathy (DPN)
Participants in this study of diabetes pain may receive
study-related medical evaluations and medication at no cost, and
compensation for time and travel.
The research site is in Alexandria, Va.
ClinicalConnection.com. All rights reserved.